BDX
Becton Dickinson & Company (BDX)
Healthcare • NYSE • $149.43-2.50%
- Symbol
- BDX
- Exchange
- NYSE
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Price
- $149.43
- Daily Change
- -2.50%
- Market Cap
- $41.17B
- Trailing P/E
- 26.12
- Forward P/E
- 11.11
- 52W High
- $187.35
- 52W Low
- $127.59
- Analyst Target
- $183.29
- Dividend Yield
- +2.81%
- Beta
- 0.28
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments. It provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal …
Company websiteResearch BDX on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.